Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

By Disease Type (Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Others), By Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Region, By Competition Forecast & Opportunities, 2018-2028F

Published	Pages	Publisher	Report code
Oct 2023	175	TechSci Research	ASDR-638159

Published: Oct 2023 - Pages : 175 - Publisher : TechSci Research - Report code : ASDR-638159

1. Novo Nordisk A/S
2. Eli Lilly and Co Ltd
3. Shire PLC
4. Sanofi SA
5. Merck KGaA
6. AstraZeneca PLC
7. AbbVie Inc
8. Actelion Pharmaceuticals Ltd
9. Amgen Inc
10. BioMarin Pharmaceutical Inc

North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market - 2025-2033

This report can be of interest as well:

North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market - 2025-2033

Published: April, 2025 | Report code: ASDR-675852